Browse the corpus

REFERENCES Cohen S, Hurd E, Cush J, et al, “Treatment of Rheumatoid Arthritis With Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Combination With Methotrexate: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial,” Arthritis Rheum , 2002, 46(3):614-24. [PubMed 11920396 ] Fleischmann RM, Schechtman J, Bennett R, et al, “Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist (r-metHuIL-1ra), in Patients With Rheumatoid Arthritis: A Large, International, Multicenter, Placebo-Controlled Trial,” Arthritis Rheum , 2003, 48(4):927-34. [PubMed 12687534 ] Fleischmann RM, Tesser J, Schiff MH, et al, Safety of Extended Treatment With Anakinra in Patients With Rheumatoid Arthritis, Ann Rheum Dis , 2006,65(8):1006-12. [PubMed 16396977 ] Genovese MC, Cohen S, Moreland L, et al, “Combination Therapy With Etanercept and Anakinra in the Treatment of Patients With Rheumatoid Arthritis Who Have Been Treated Unsuccessfully With Methotrexate,” Arthritis Rheum , 2004, 50(5):1412-9. [PubMed 15146410 ] Rigante D, Leone A, Marrocco R, et al, “Long-Term Response After 6-Year Treatment With Anakinra and Onset of Focal Bone Erosion in Neonatal-Onset Multisystem Inflammatory Disease (NOMID/CINCA),” Rheumatol Int , 2011, 31(12):1661-4. [PubMed 21240490 ] Sibley CH, Plass N, Snow J, et al,” Sustained Response and Prevention of Damage Progression in Patients With Neonatal-Onset Multisystem Inflammatory Disease Treated With Anakinra: A Cohort Study to Determine Three- and Five-Year Outcomes,” Arthritis Rheum , 2012, 64(7):2375-86. [PubMed 22294344 ] Yang B, Baughman S, and Sullivan JT, “Pharmacokinetics of Anakinra in Subjects With Different Levels of Renal Function,” Clin Pharmacol Ther , 2003, 74(1):85-94. [PubMed 12844139 ] Topic 9246 Version 36.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-115.25.216.6-3A7D25EF8E-S244013.14]